Glaxosmithkline | GSK - Ebit





Ebit Alterar Data
AbbVie USD 6.88B 156M 2026-09
Amgen USD 4.68B 65M 2026-09
AstraZeneca USD 4.66B 1.5B 2026-09
Aurora Cannabis CAD -3.17M 10.29M 2026-06
Bausch Health Companies USD 993M 217M 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
Canopy Growth CAD -2.03M 143.62M 2026-06
Corcept Therapeutics USD 114.72M 73.42M 2026-09
Drreddys Laboratories INR 13.52B 10.47B 2026-09
Eli Lilly USD 13.09B 635M 2026-09
GlaxoSmithKline GBP 2.86B 251M 2026-09
Glaxosmithkline GBP 2.15B 157M 2026-09
J&J USD 6.47B 1B 2026-09
Merck USD 7.33B 6.49B 2026-09
Novartis USD 5.14B 411M 2026-09
Pacira USD 2.57B 2.56B 2026-09
Perrigo USD 27.2M 116.6M 2026-09
Pfizer USD 4.85B 5.03B 2026-09
Phibro Animal Health USD 54.99M 2.36M 2025-12
Prestige Brands USD 52.52M 22.97M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 4.72B 3.6B 2026-09
Supernus Pharmaceuticals USD -21.04M 14.21M 2026-06
Takeda JPY 205.32B 3.9B 2026-09
Teva Pharmaceutical Industries USD 1.19B 954M 2026-09
Zoetis USD 1.03B 88M 2026-09